NASDAQ:COCP

Cocrystal Pharma, Inc Earning Date

USA |NASDAQ |USD

COCP Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 15, 2021 Sep 2021 $-0.03 $-0.04 $-0.05
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 15, 2021 Sep 2021 $270.00K $0.00 $489.00K

Cocrystal Pharma, Inc's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 2021.

COCP Earnings Date & History Chart

COCP Earnings & Revenue Forecast

COCP Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.04 $-0.05 $-0.03
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.14 $-0.17 $-0.12
Dec 2022 2 $-0.15 $-0.15 $-0.15

COCP Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.04 $-0.03 $-0.03
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.14 $-0.13 $-0.13
Dec 2022 0 / 0 $-0.15 $-0.15 $-0.15

COCP Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 2 $270.00K $0.00 $550.00K
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $820.00K $0.00 $1.65M
Dec 2022 1 $2.40M $2.40M $2.40M

COCP Earnings Date & Revenue History

COCP Earnings History

|
Show More
Show More

COCP Revenue History

|
Show More
Show More

Cocrystal Pharma, Inc Next Earnings Date & Report

COCP Next Earnings Date & Report Preview: Sep 2021 (FQ)

COCP's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 2 analysts, the average EPS estimation for Cocrystal Pharma, Inc's next quarterly earnings is $-0.03, with a low EPS estimation of $-0.04, and a high estimation of $-0.03.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.03, the last 2 month trend is $-0.03, and the 3 month trend is $-0.03.

Based on 2 analysts, the average revenue estimation is $270.00K, with a low revenue estimation of $0.00, and a high estimation of $550.00K.

Cocrystal Pharma, Inc Previous Earnings Dates & Reports

COCP Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Cocrystal Pharma, Inc's previous earnings date was Aug 16, 2021 for its fiscal quarter ended Jun 30, 2021.

COCP's earnings per share (EPS) was $-0.04, missing the consensus analysts forecast of $-0.04 by -14.29%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by 0.00%, and higher than the same period a year before (Jun 2020) by -39.58%.

Revenues were $0.00.

The company reported a net income of $-3.82M.

Free cash flow for the quarter was $-2.64M , compared to $-1.79M last quarter and $-2.33M a year before.

COCP ended the quarter with $480.00K in total debt, a decrease of -10.95% compared to the previous quarter, and a decrease of -32.01% compared to the same quarter a year before.

COCP Previous Earnings Date & Report Recap: Dec 2020 (FY)

Cocrystal Pharma, Inc's previous annual earnings date was Mar 17, 2021 for its fiscal year ended Dec 31, 2020.

COCP's earnings per share (EPS) was $-0.17, beating the consensus analysts forecast of $-0.20 by -13.45% , and lower than the previous year's EPS (Dec 2019) by 62.99%.

Revenues were $2.01M, worse than the forecast of $2.15M by -6.33%, and down by -69.32% from previous year's revenue.

The company reported a net income of $-9.65M.

Cocrystal Pharma, Inc reported a free cash flow of $-10.07M for its fiscal year, compared to $-1.71M a year ago.

The company ended the fiscal year with $596.00K in total debt, a decrease of -27.05% compared to the previous year.